Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb 7;11(1):104.
doi: 10.1186/s13104-018-3225-9.

Incidence of acute lymphocytic leukemia in Calgary, Alberta, Canada: a retrospective cohort study

Affiliations

Incidence of acute lymphocytic leukemia in Calgary, Alberta, Canada: a retrospective cohort study

Rayven Snodgrass et al. BMC Res Notes. .

Abstract

Objective: Acute lymphocytic leukemia (ALL) is a rare malignant neoplasm that develops from abnormal lymphoid stem cells. ALL incidence is highest among children and declines towards adolescence. There is limited data on the epidemiology of ALL, especially in Canada. This retrospective cohort study used patient data from the Calgary Laboratory Services Cancer Cytogenetics Laboratory to report the incidence rate of ALL in Calgary, Alberta, Canada. New cases of ALL were identified for the 5-year period of January 1, 2011 until December 31, 2015. Reported incidence rates were categorized by sex and age groups, and age-standardized to the Canadian population.

Results: There were an average of 11.4 new cases of ALL diagnosed per year between 2011 and 2015. The total incidence rate per 100,000 person-years was 0.84. Incidence rates peaked in children aged 0-4 with 7.55 and 3.32 cases per 100,000 person-years for males and females, respectively. The median age of diagnosis was 8 years. Incidence rates were generally lowest for adults aged 20 and over. The ratio of males to females diagnosed with ALL was 1.59. Overall, the recent incidence of ALL in Calgary is comparatively low with a preference for males and children below 5 years of age.

Keywords: Acute lymphoblastic leukemia; Canada; Cancer epidemiology; Childhood leukemia; Hematologic neoplasm.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Age and sex-categorized incidence rates of acute lymphoblastic leukemia in the Calgary metropolitan area (2011–2015)

References

    1. Sawyers CL, Denny CT, Witte ON. Leukemia and the disruption of normal hematopoiesis. Cell. 1991;64(2):337–350. doi: 10.1016/0092-8674(91)90643-D. - DOI - PubMed
    1. Cortes JE, Kantarjian HM. Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy. Cancer. 1995;76(12):2393–2417. doi: 10.1002/1097-0142(19951215)76:12<2393::AID-CNCR2820761203>3.0.CO;2-P. - DOI - PubMed
    1. Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®). Bethesda, MD. 2016. https://www.cancer.gov/types/leukemia/patient/child-all-treatment-pdq. Accessed 10 Aug 2017.
    1. 2012 report on cancer statistics in Alberta—childhood cancer. Edmonton, AB. 2015. http://www.albertahealthservices.ca/assets/healthinfo/poph/hi-poph-surv-.... Accessed 10 Aug 2017.
    1. Katz AJ, Chia VM, Schoonen WM, Kelsh MA. Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden. Cancer Causes Control. 2015;26(11):1627–1642. doi: 10.1007/s10552-015-0657-6. - DOI - PubMed

LinkOut - more resources